Cytek Biosciences Inc.

CTKB | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.28

-$0.02 (-0.38%)

At close: Sep 21, 2026, 4:00 PM ET

$5.48

+$0.20 (+3.79%)

Pre-market: Sep 22, 2026, 7:42 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.38%

(1D)

Rating

Updated: Aug 31, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $681.87M

1D Range

5.20 5.32

52W Range

3.28 6.18

Valuation (TTM)

PE -8.52

PB 2.12

EV/EBITDA -14.81

Valuation (NTM)

Forward PE N/A

Forward PEG 0.32

Price Target $4.88

Cash Flow

FCF Yield -2.5%

SBC Adj. FCF Yield -6.3%

SBC Impact -154.4%

Margins

Gross Margin 53.2%

Operating Margin -21.6%

FCF Margin -8.2%

Growth (CAGR)

Revenue 3Y | 5Y 5.6% | 13.4%

Dil EPS 3Y | 5Y -91.4% | -72.7%

FCF 3Y | 5Y -875.2% | 19.9%

Returns

ROA -18.0%

ROE -23.5%

ROIC -11.9%

Financial Health

Net Cash

$252.33M

Current Ratio 4.48

Interest Coverage -25.34

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary ...

Sector Healthcare

Industry Medical - Devices

Employees 682

IPO Date Jul 22, 2021

Website cytekbio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 4, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$4.88

Downside

-7.58%

Buy (3)

Hold (0)

Sell (0)

Analyst Details ➞